Related Experiment Video
Updated: Jan 22, 2026

09:05
In Vitro Differentiation of Human Mesenchymal Stem Cells into Functional Cardiomyocyte-like Cells
Published on: August 9, 2017
11.4K
Pacemaker cell characteristics of differentiated and HCN4-transduced human mesenchymal stem cells
Fabrice F Darche1, Rasmus Rivinius1, Eva Köllensperger2
1Department of Cardiology, Medical University Hospital Heidelberg, INF 410, D-69120 Heidelberg, Germany.
Life Sciences
|July 11, 2019
Summary
Human mesenchymal stem cells (haMSC) differentiated and transduced with HCN4 show potential as biological pacemakers. This approach offers a promising alternative to electronic devices for controlling heart rate.
Area of Science:
- Regenerative Medicine & Cardiology
- Stem Cell Biology
- Biomedical Engineering
Background:
- Electronic pacemakers have limitations and side effects.
- Cell-based biological pacemakers offer a potential alternative.
- Mesenchymal stem cells (MSCs) are being investigated for cardiac applications.
Purpose of the Study:
- To develop and test nodal-type differentiation of human adipose-derived (haMSC) and bone marrow-derived (hbMSC) mesenchymal stem cells.
- To evaluate the potential of these differentiated cells as biological pacemakers.
- To investigate the role of the HCN4 channel in cellular pacemaking function.
Main Methods:
- Customized differentiation protocols for haMSC and hbMSC.
- Quantitative RT-PCR for gene expression profiling of pacemaker-related genes.
- Immunocytochemistry for protein membrane expression analysis.
- Patch clamp recordings to study pacemaker current (If) in haMSC.
- Lentiviral transduction of haMSC with HCN4.
- Co-culture experiments with neonatal rat ventricular myocytes (NRVM) to assess functional characteristics.
Main Results:
- Differentiated haMSC and hbMSC showed abundant transcription of ion channel, transcription factor, and connexin genes characteristic of cardiac pacemaker tissue, but lacked adequate HCN transcription.
- haMSC-derived cells exhibited transcriptional profiles closer to sinoatrial nodal cells compared to hbMSC-derived cells.
- Lentiviral HCN4-transduction of haMSC resulted in stable If, enabling spontaneous contractions in co-culture with NRVM.
- Differentiated haMSC expressing HCN4 demonstrated improved beating rate, regularity, synchrony, and earlier onset of contractions compared to controls.
- Increased membrane expression of cardiac gap junctional proteins was observed in differentiated haMSC.
Conclusions:
- Differentiated haMSC, not hbMSC, possess favorable properties for cardiac pacemaking.
- Lentiviral HCN4-transduction of differentiated haMSC generates a cellular phenotype capable of sustainably controlling and stabilizing heart rate.
- This study presents a promising strategy for developing cell-based biological pacemakers.
Related Concept Videos
Mesenchymal Stem Cells
5.5K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.5K
Adult Stem Cells
33.4K
Stem cells are undifferentiated cells that divide and produce more stem cells or progenitor cells that differentiate into mature, specialized cell types. All the cells in the body are generated from stem cells in the early embryo, but small populations of stem cells are also present in many adult tissues including the bone marrow, brain, skin, and gut. These adult stem cells typically produce the various cell types found in that tissue—to replace cells that are damaged or to continuously...
33.4K
Embryonic Stem Cells
32.1K
Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
32.1K
Embryonic Stem Cells
4.8K
Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
4.8K
Induced Pluripotent Stem Cells
27.3K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
27.3K
B Cell Activation and Differentiation
16.2K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
16.2K

